| Patents for C07K 4 - Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof (2,102) |
|---|
| 05/25/2006 | US20060111551 Peptide having HTLV-1-specific CTL-inducing activity |
| 05/24/2006 | EP1658036A2 Estrogen receptor modulators and uses thereof |
| 05/23/2006 | US7049293 Peptide and osteogenetic accelerator |
| 05/18/2006 | US20060107351 Cell visual characteristic-modifying sequences |
| 05/18/2006 | US20060104992 Irreversibly-inactivated pepsinogen fragment and pharmaceutical compositions comprising this fragment for detecting, preventing, and treating HIV |
| 05/17/2006 | EP0973391B1 Endoderm, cardiac and neural inducing factors |
| 05/10/2006 | EP1653986A2 Treatment of cancers expressing p95 erbb2 |
| 05/09/2006 | US7041442 peptides or derivatives of the 65 kD lower matrix phoshpoprotein of HCMV useful for determining whether subjects have been exposed to the virus and for determining the peptide-induced production of interferon- gamma and/or TNF- alpha in CD8+ T cells isolated from subjects |
| 05/03/2006 | CN1765921A Separated soybean protein preparation process and prepared soybean small peptide and process |
| 05/02/2006 | US7038011 Methods and tools for identifying compounds which modulate atherosclerosis by impacting LDL-proteoglycan binding |
| 04/25/2006 | US7033597 Intracellular delivery of biological effectors |
| 04/20/2006 | WO2004091493A3 Improved heat shock protein-based vaccines and immunotherapies |
| 04/19/2006 | EP1646646A1 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof. |
| 04/19/2006 | CN1761482A Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
| 04/18/2006 | US7030227 Cell regulatory genes, encoded products, and uses related thereto |
| 04/18/2006 | US7029858 Genetic engineering; binding collagen to integrins; vaccine |
| 04/12/2006 | EP1644729A2 Anti-cd74 immunoconjugates and methods |
| 04/12/2006 | EP1644402A1 Arginine/lysine-enriched peptides |
| 04/12/2006 | EP1005356B1 Novel antibacterial agents |
| 04/06/2006 | US20060073575 Methods and reagents for assaying protein kinase activity |
| 04/05/2006 | EP0946188B1 Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
| 03/30/2006 | US20060068444 Compositions and methods for detecting cyclic analogs of hPTH |
| 03/23/2006 | WO2006030722A1 Amino acid sequence essential to neurospecific gene expression |
| 03/22/2006 | EP1635692A2 Monitoring immunologic, hematologic and inflammatory diseases |
| 03/22/2006 | CN1749268A IIAb18G/CD147 function epitope amino acid sequence of series monoanti-body function and its use |
| 03/15/2006 | EP1162997B1 Staphylococcus antigen and vaccine |
| 03/14/2006 | US7012128 Interaction between cyclin D1 and steroid receptor co-activators and uses thereof in assays |
| 03/02/2006 | WO2005090404A3 Compositions and methods for detecting cyclic analogs of human parathyroid hormone (hpth) |
| 03/02/2006 | WO2004092332A3 Sars virus polypeptides |
| 02/21/2006 | CA2091181C Cloning of chicken anaemia dna |
| 02/16/2006 | US20060036070 Immunoglobulin a inducing protein and uses therefor |
| 02/16/2006 | US20060035260 Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses |
| 02/15/2006 | EP1626054A1 Oligopeptide |
| 02/08/2006 | EP1622563A2 Improved heat shock protein-based vaccines and immunotherapies |
| 02/01/2006 | EP1621554A1 Immunoglobulins devoid of light chains |
| 01/26/2006 | CA2574665A1 Therapeutic and diagnostic agents |
| 01/25/2006 | EP1619202A2 immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 01/25/2006 | EP1617804A2 Improved heat shock protein-based vaccines and immunotherapies |
| 01/25/2006 | CN1238366C Selection of proteins using RNA-protein fusions |
| 01/19/2006 | US20060014933 Using amines or amino acids as mobile phase modifiers in chromatography |
| 01/19/2006 | US20060014926 Human papillomavirus E6 and E7 polypeptides, mutant polypeptide retains 30% of the immunogenicity of an isolated polypeptide comprising human wild-type papillomavirus E6 and E7 |
| 01/18/2006 | EP1127068B1 Immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 01/05/2006 | US20060004184 Method and device for detecting feline immunodeficiency virus |
| 01/05/2006 | US20060004077 Inhibiting class II MHC-mediated activation of T cells; peptidomimetics of given sequence which include a Gpg (guanylpiperidyl glycine) unit; rheumatoid arthritis and/or multiple sclerosis; e.g. Ac-Cha-Gpg-Tic-Nle-NHCH2CH2Ph (Cha=cyclohexylalanine, Tic=3-carboxyisoquinoline, Nle=norleucine) |
| 01/03/2006 | US6982149 Fiber array and methods for using and making same |
| 12/29/2005 | US20050288231 Biologically active peptides as glutamate receptor inhibitors |
| 12/22/2005 | WO2005121166A1 Novel immunointeractive molecules and uses thereof |
| 12/21/2005 | EP1606232A1 Improved extraction process |
| 12/15/2005 | WO2005056572A3 Clustered multi-antigenic carbohydrate constructs, methods for their preparation and uses thereof |
| 12/14/2005 | EP1604032A2 Method for detecting prognosis of cancer |
| 12/13/2005 | US6974864 Viral mucleotide sequences for use in the diagnosis and treatment of viral diseases |
| 12/01/2005 | WO2003085122A3 Endophytic streptomycetes from higher plants with biological activity |
| 11/17/2005 | US20050256049 Chimeric toxins for targeted therapy |
| 11/16/2005 | EP1594442A2 Knockout identification of target-specific sites in peptides |
| 11/16/2005 | CN1697792A Improved extraction process |
| 11/02/2005 | EP1590434A2 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
| 10/26/2005 | EP1589107A1 Immunoglobulins devoid of light chains |
| 10/06/2005 | US20050222041 oligopeptides capable of stimulating neural cell adhesion molecule (NCAM) signalling and/or interfering with cell adhesion, used for treatment of nervous system disorders |
| 09/29/2005 | WO2005090404A2 Compositions and methods for detecting cyclic analogs of human parathyroid hormone (hpth) |
| 09/29/2005 | WO2005068087A3 Method for coating an object with hydrophobin at low temperatures |
| 09/29/2005 | US20050214300 Methods for treating cancer using Porimin as a target |
| 09/29/2005 | CA2562133A1 Compositions and methods for detecting cyclic analogs of human parathyroid hormone (hpth) |
| 09/28/2005 | EP1578993A2 METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IgE SYNTHESIS UTILIZING A B-CELL ASSOCIATED PROTEIN |
| 09/22/2005 | WO2005087927A1 Method for preparation and purification or recombinant proteins |
| 09/22/2005 | WO2005034844A3 Exosite-directed thrombin inhibitors |
| 09/21/2005 | EP1575988A2 Short peptides from the '2nd loop' of 7 transmembrane receptor which selectively modulate signal transduction |
| 09/21/2005 | EP1575602A2 Methods for treating cancer using porimin as a target |
| 09/21/2005 | EP1575525A2 Cell surface tropomyosin as a target of angiogenesis inhibition |
| 09/21/2005 | EP1575524A2 Proliferated cell lines and uses thereof |
| 09/21/2005 | EP1404377B1 Improved chelator conjugates |
| 09/14/2005 | EP1573025A2 Crystallized structure of type iv collagen nc1 domain hexamer |
| 09/14/2005 | EP1573023A2 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
| 09/14/2005 | EP1572149A2 Immunogenicity of glucan binding protein |
| 09/14/2005 | EP1572066A2 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2 |
| 08/24/2005 | EP1019075B1 Beta 2-adrenergic receptor agonists |
| 08/23/2005 | US6933271 Aimed at neoplastic cells with gonadotropin releasing hormone binding sites; anticarcinogenic agents; genetically engineered Pseudomonas Exotoxin |
| 08/23/2005 | US6932965 Separation of deamidated and non-deamidated human dnases and use of the non-deamidated species as a pharmaceutical per se; administering to patients suffering from pulmonary distress |
| 08/11/2005 | US20050175631 Hiv vaccine and method of use |
| 08/10/2005 | CN1652810A Immunosuppressant compounds, methods and uses related thereto |
| 08/03/2005 | EP1558354A2 Using amines or amino acids as mobile phase modifiers in chromatography |
| 07/28/2005 | WO2005068087A2 Method for coating an object with hydrophobin at low temperatures |
| 07/21/2005 | WO2005011607A3 Treatment of cancers expressing p95 erbb2 |
| 07/07/2005 | WO2005040193A3 Synthetic peptides that cause f-actin bundling and block actin depolymerization |
| 07/06/2005 | EP1549335A1 A method of modulating cellular activity and molecules for use therein |
| 07/06/2005 | EP0817846B1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies |
| 06/30/2005 | US20050142166 Fermenting food material comprising animal milk proteins (casein) or vegetable proteins with proteolytic lactic acid bacterium and lytic lactic acid bacterium (lactobacillus, lactococcus) |
| 06/23/2005 | WO2005056572A2 Clustered multi-antigenic carbohydrate constructs, methods for their preparation and uses thereof |
| 06/02/2005 | WO2005018575A3 Estrogen receptor modulators and uses thereof |
| 06/02/2005 | WO2004112572A3 Monitoring immunologic, hematologic and inflammatory diseases |
| 06/02/2005 | WO2004065547A3 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
| 05/26/2005 | WO2005009363A3 Treatment of pre-cancerous conditions and prevention of cancer using pcdgf-based therapies |
| 05/26/2005 | WO2005009217A3 Diagnosis of pre-cancerous conditions using pcdgf agents |
| 05/26/2005 | US20050112559 Compositions and methods for diagnosing and preventing severe acute respiratory syndrome (SARS) |
| 05/24/2005 | US6897198 Method of treatment with combinations of statin and aryl-substituted propanolamine derivatives |
| 05/12/2005 | CA2541856A1 Modified polypeptides with therapeutic activity and methods of use |
| 05/06/2005 | WO2005040193A2 Synthetic peptides that cause f-actin bundling and block actin depolymerization |
| 05/06/2005 | CA2542922A1 Protein expression |
| 05/05/2005 | US20050095241 Estrogen receptor modulators and uses thereof |
| 04/28/2005 | WO2004110390A3 Anti-cd74 immunoconjugates and methods |
| 04/28/2005 | WO2004011486A8 Method for solubilizing hydrophobic peptides and use thereof for inducing an antitumoral and/or anti-infectious ctl response |